Cargando…

Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea

BACKGROUND: Data on the clinical characteristics of pediatric patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant infection are limited. We aimed to evaluate the clinical features and outcomes of children with SARS-CoV-2 infection before and after omicron variant domin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Soo-Han, Choi, Jae Hong, Lee, Joon Kee, Eun, Byung-Wook, Song, Seung Ha, Ahn, Bin, Kim, Ye Kyung, Yun, Ki Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988433/ https://www.ncbi.nlm.nih.gov/pubmed/36880106 http://dx.doi.org/10.3346/jkms.2023.38.e65

Ejemplares similares

Estimating the incubation period of SARS-CoV-2 Omicron BA.1 variant in comparison with that during the Delta variant dominance in South Korea
por: Liu, Yanwen, et al.
Publicado: (2022)

Etiology and Epidemiology of Croup before and throughout the COVID-19 Pandemic, 2018–2022, South Korea
por: Lee, Joon Kee, et al.
Publicado: (2022)

Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality
por: Karageorgou, Vagia, et al.
Publicado: (2023)

Evaluation of COVID-19 vaccine effectiveness in different high-risk facility types during a period of Delta variant dominance in the Republic of Korea: a cross-sectional study
por: Lee, Min Jei, et al.
Publicado: (2023)

Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
por: Kim, Yoo-Yeon, et al.
Publicado: (2023)

SARS-CoV-2-Naïve Korean Children and Adolescents Hospitalized With COVID-19 in 2021
por: Choi, Youn Young, et al.
Publicado: (2022)

Household secondary attack rates and risk factors during periods of SARS-CoV-2 Delta and Omicron variant predominance in the Republic of Korea
por: Lee, Jin, et al.
Publicado: (2023)

Shift in Clinical Epidemiology of Human Parainfluenza Virus Type 3 and Respiratory Syncytial Virus B Infections in Korean Children Before and During the COVID-19 Pandemic: A Multicenter Retrospective Study
por: Kim, Ye Kyung, et al.
Publicado: (2022)

Clonal Expansion of Macrolide-Resistant Sequence Type 3 Mycoplasma pneumoniae, South Korea
por: Lee, Joon Kee, et al.
Publicado: (2018)

The Detection of Periodic Reemergence Events of SARS-CoV-2 Delta Strain in Communities Dominated by Omicron
por: Westcott, Claire E., et al.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccine Elicits Sustained T Cell Responses Against the Omicron Variant in Adolescents
por: Choi, Sujin, et al.
Publicado: (2023)

Statement on healthcare system preparedness in response to COVID-19 Omicron subvariants BA.4 and BA.5 surge in Korea from the Korean Pediatric Society and Korean Society of Pediatric Infectious Diseases
por: Cho, Eun Young, et al.
Publicado: (2022)

Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study
por: Stock, Sarah J, et al.
Publicado: (2022)

Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings
por: Dobrowolska, Krystyna, et al.
Publicado: (2023)

Reproduction Number of the Omicron Variant Triples That of the Delta Variant
por: Du, Zhanwei, et al.
Publicado: (2022)

Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021
por: Kim, Eun-Young, et al.
Publicado: (2022)

Genomic epidemiology of SARS- CoV-2 Omicron variants in the Republic of Korea
por: Lee, Dong-Wook, et al.
Publicado: (2022)

Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore
por: Zeng, Kangwei, et al.
Publicado: (2023)

Long-term Tolvaptan Treatment of Autosomal Dominant Polycystic Kidney Disease in Korea
por: Kim, Ha Yeon, et al.
Publicado: (2018)

Will New Variants Emerge after Delta and Omicron?
por: Yang, Zhen, et al.
Publicado: (2022)

Distinct Clinical and Laboratory Features of COVID-19 in Children During the Pre-Delta, Delta and Omicron Wave
por: Han, Mi Seon, et al.
Publicado: (2023)

259. Comparison of the causes of death in patients with delta variant versus omicron variant infections
por: Reum Kim, A, et al.
Publicado: (2022)

COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods
por: Mayr, Florian B., et al.
Publicado: (2022)

Clinical Characteristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea
por: Kim, Min-Kyung, et al.
Publicado: (2022)

An Analysis of COVID-19 Mortality During the Dominancy of Alpha, Delta, and Omicron in the USA
por: Tabatabai, Mohammad, et al.
Publicado: (2023)

Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
por: Kim, A Reum, et al.
Publicado: (2023)

2298. Penetration of SARS-CoV-2 Alpha, Delta, and Omicron Variants in the USA
por: Choi, Hosoon, et al.
Publicado: (2023)

Will the COVID-19 pandemic end with the Delta and Omicron variants?
por: Wang, Chaoqi, et al.
Publicado: (2022)

Comparison of risk factors for SARS-CoV-2 infection among healthcare workers during Omicron and Delta dominance periods in Japan
por: Li, Y., et al.
Publicado: (2023)

Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance
por: Flisiak, Robert, et al.
Publicado: (2022)

Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods
por: Shoji, Kensuke, et al.
Publicado: (2023)

Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2
por: Park, Sang Woo, et al.
Publicado: (2023)

mRNA vaccine effectiveness against SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant transmission from home care cases to household contacts in South Korea
por: Park, Hanul, et al.
Publicado: (2022)

GenomeBits insight into omicron and delta variants of coronavirus pathogen
por: Canessa, Enrique, et al.
Publicado: (2022)

Analysis of Factors Influencing the Clinical Severity of Omicron and Delta Variants
por: Zhao, Shanlu, et al.
Publicado: (2023)

Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study
por: Nielsen, Katrine Finderup, et al.
Publicado: (2022)

Correction: Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance
por: Flisiak, Robert, et al.
Publicado: (2022)

Alterations in smell or taste in individuals infected with SARS-CoV-2 during periods of Omicron variant dominance
por: Song, Jian, et al.
Publicado: (2023)

Severity predictors of COVID-19 in SARS-CoV-2 variant, delta and omicron period; single center study
por: Ogawa, Fumihiro, et al.
Publicado: (2022)

Risk Factors Related to COVID-19 Reinfection and Fatality During the Omicron (BA.1/BA.2) Period in Korea
por: Lee, Ju Hee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3ii9kvn7sltv8u3jjea5hkq94f